领航医药生物科技公布配售协议失效

Group 1 - The company, Pioneer Pharma Biotech (00399), announced a share placement at a price of HKD 0.415 per share, with a maximum of 145 million shares to be placed [1] - The placement agreement has become invalid as the conditions precedent were not met by September 11, 2025, and the placement will not proceed [1] - All responsibilities under the placement agreement between the placement agent and the company will terminate, and no claims can be made by either party regarding the placement agreement [1]